Fibrocell Science, Inc. announced the appointment of Greg Weaver as Chief Financial Officer, Senior Vice President, Treasurer and Corporate Secretary of the company. Weaver replaces Declan Daly, who will leave the company to reside full time in Ireland. Weaver and Daly will work side by side through November 2013 to assure a smooth financial leadership transition.

Weaver brings more than thirty years of strategic and financial management experience to the company, where he will be responsible for the company's day-to-day financial operations at the corporate offices in Exton, Pa. He joins Fibrocell from Celsion Corp. where he served as chief financial officer after serving six years on Celsion's board of directors.

Prior to Celsion, Weaver served as CFO for six other biotechnology companies, including Poniard Pharmaceuticals, Talyst, Inc., Sirna Therapeutics, Nastech Pharmaceutical Co., Ilex Oncology and Prism Technologies and consulted for countless others.